JI LIN AO DONG: The hydrochloride naloxone injection has passed the consistency evaluation of quality and efficacy for generic drugs

JI LIN AO DONG announced that its holding subsidiary Yanji Pharmaceutical has received the "Drug Supplement Application Approval Notice" for "Naloxone Hydrochloride Injection" issued by the National Medical Products Administration. The drug's generic name is Naloxone Hydrochloride Injection, with a specification of 1ml: 0.4mg, and the original drug approval number is Guo Yao Zhun Zi H20066188. The approval of the consistency evaluation of the quality and efficacy of the generic drug is beneficial for expanding the market share of this drug and enhancing market competitiveness. It is expected that there will be no significant impact on the company's performance in the short term